Cargando…
Long-term Outcome of Chilblains Associated with SARS-CoV-2
Numerous cases of chilblains have been observed in the course if the COVID-19 pandemic. The aims of this study were to provide comprehensive follow-up data for patients reporting chilblains, and to determine the risk factors for incomplete recovery. Patients referred to 5 hospitals in France between...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Society for Publication of Acta Dermato-Venereologica
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472087/ https://www.ncbi.nlm.nih.gov/pubmed/34515805 http://dx.doi.org/10.2340/00015555-3930 |
_version_ | 1784789230447230976 |
---|---|
author | POIZEAU, Florence BARBAROT, Sébastien LE CORRE, Yannick BRENAUT, Emilie SAMIMI, Mahtab AUBERT, Hélène TOUBEL, Alexis DUPUY, Alain |
author_facet | POIZEAU, Florence BARBAROT, Sébastien LE CORRE, Yannick BRENAUT, Emilie SAMIMI, Mahtab AUBERT, Hélène TOUBEL, Alexis DUPUY, Alain |
author_sort | POIZEAU, Florence |
collection | PubMed |
description | Numerous cases of chilblains have been observed in the course if the COVID-19 pandemic. The aims of this study were to provide comprehensive follow-up data for patients reporting chilblains, and to determine the risk factors for incomplete recovery. Patients referred to 5 hospitals in France between March and May 2020 for chilblains were surveyed on December 2020. A teleconsultation was offered. Among 82 patients reporting chilblains, 27 (33%) reported complete recovery, 33 (40%) had recurrences of chilblains after their hands and feet had returned to normal, and 22 (27%) developed persistent acral manifestations, mostly acrocyanosis, with or without further recurrences of chilblains. Most recurrences of chilblains occurred during the following autumn and winter. A past history of chilblains was not associated with recurrences or persistent acral manifestations. Women had a significantly higher risk of developing recurrences or persistent acral manifestations (odds ratio 1.30; 95% confidence interval 1.06–1.59). In conclusion, two-thirds of patients reporting chilblains at the start of the COVID-19 pandemic experienced persistent or recurrent acral manifestations after a 10-month follow-up. |
format | Online Article Text |
id | pubmed-9472087 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Society for Publication of Acta Dermato-Venereologica |
record_format | MEDLINE/PubMed |
spelling | pubmed-94720872022-10-20 Long-term Outcome of Chilblains Associated with SARS-CoV-2 POIZEAU, Florence BARBAROT, Sébastien LE CORRE, Yannick BRENAUT, Emilie SAMIMI, Mahtab AUBERT, Hélène TOUBEL, Alexis DUPUY, Alain Acta Derm Venereol Clinical Report Numerous cases of chilblains have been observed in the course if the COVID-19 pandemic. The aims of this study were to provide comprehensive follow-up data for patients reporting chilblains, and to determine the risk factors for incomplete recovery. Patients referred to 5 hospitals in France between March and May 2020 for chilblains were surveyed on December 2020. A teleconsultation was offered. Among 82 patients reporting chilblains, 27 (33%) reported complete recovery, 33 (40%) had recurrences of chilblains after their hands and feet had returned to normal, and 22 (27%) developed persistent acral manifestations, mostly acrocyanosis, with or without further recurrences of chilblains. Most recurrences of chilblains occurred during the following autumn and winter. A past history of chilblains was not associated with recurrences or persistent acral manifestations. Women had a significantly higher risk of developing recurrences or persistent acral manifestations (odds ratio 1.30; 95% confidence interval 1.06–1.59). In conclusion, two-thirds of patients reporting chilblains at the start of the COVID-19 pandemic experienced persistent or recurrent acral manifestations after a 10-month follow-up. Society for Publication of Acta Dermato-Venereologica 2021-12-13 /pmc/articles/PMC9472087/ /pubmed/34515805 http://dx.doi.org/10.2340/00015555-3930 Text en © 2021 Acta Dermato-Venereologica https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the CC BY-NC license |
spellingShingle | Clinical Report POIZEAU, Florence BARBAROT, Sébastien LE CORRE, Yannick BRENAUT, Emilie SAMIMI, Mahtab AUBERT, Hélène TOUBEL, Alexis DUPUY, Alain Long-term Outcome of Chilblains Associated with SARS-CoV-2 |
title | Long-term Outcome of Chilblains Associated with SARS-CoV-2 |
title_full | Long-term Outcome of Chilblains Associated with SARS-CoV-2 |
title_fullStr | Long-term Outcome of Chilblains Associated with SARS-CoV-2 |
title_full_unstemmed | Long-term Outcome of Chilblains Associated with SARS-CoV-2 |
title_short | Long-term Outcome of Chilblains Associated with SARS-CoV-2 |
title_sort | long-term outcome of chilblains associated with sars-cov-2 |
topic | Clinical Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472087/ https://www.ncbi.nlm.nih.gov/pubmed/34515805 http://dx.doi.org/10.2340/00015555-3930 |
work_keys_str_mv | AT poizeauflorence longtermoutcomeofchilblainsassociatedwithsarscov2 AT barbarotsebastien longtermoutcomeofchilblainsassociatedwithsarscov2 AT lecorreyannick longtermoutcomeofchilblainsassociatedwithsarscov2 AT brenautemilie longtermoutcomeofchilblainsassociatedwithsarscov2 AT samimimahtab longtermoutcomeofchilblainsassociatedwithsarscov2 AT auberthelene longtermoutcomeofchilblainsassociatedwithsarscov2 AT toubelalexis longtermoutcomeofchilblainsassociatedwithsarscov2 AT dupuyalain longtermoutcomeofchilblainsassociatedwithsarscov2 |